by David Cassak
In many respects, the orthopedics industry, and in particular the joint replacement part of it, seems like a profoundly conservative industry. Success rates for existing devices are extremely high, leaving...
One of the most innovative and creative orthopedic implant designers, the UK's Finsbury's Orthopedics never quite built the sales and distribution capability to enable it to capture the full value of its designs. The company's recent sale to DePuy underscores how much the orthopedics industry has changed since its earliest days.
by David Cassak
In many respects, the orthopedics industry, and in particular the joint replacement part of it, seems like a profoundly conservative industry. Success rates for existing devices are extremely high, leaving...
BioWales in London 2025 showcased the efforts healthtech innovators are making to meet investors on their own turf, illustrating changing attitudes and evolving needs.
Metsera CEO Whit Bernard applies an unconventional leadership philosophy to develop next-generation obesity therapeutics, including monthly GLP-1 injections and oral peptides.
The UK government has prioritized synthetic biology and created a "concierge service" for biotechs just as the US cuts science funding.